Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Mattel Inc (MAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Mattel Inc — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Mattel Inc trades at $16.65 (market cap $4.80B). The key difference: Hinge Health Inc. Class A Common Stock is the larger of the two by market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Mattel Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Mattel Inc for 97 Days on average.
| HNGE | MAT | |
|---|---|---|
Market Cap | $8.48B | $4.80B |
Volume | 879,799 | 4,615,998 |
Sector | Health | Consumer Cyclical |
52-Week High | $105.14 | $22.16 |
52-Week Low | $31.17 | $12.66 |
Typical Hold Time | 0 Days | 97 Days |
Enterprise Value | $8.10B | $7.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Mattel (MAT) trades at $16.65, down 0.66% with mixed technical signals showing bullish moving averages but overbought RSI levels. The company maintains stable revenue around $5.3-5.5B with 7.78% net margins and attractive valuation ratios (P/E 12.53, P/S 0.93). Recent CEO transition and takeover interest from Authentic Brands Group create significant near-term catalysts, though earnings have shown volatility with two recent quarterly misses.
The stock presents a compelling risk-reward with strong brand portfolio and takeover speculation offsetting execution risks during leadership transition. Analyst consensus leans bullish (54% buy ratings) with $16.25 price target, though investors should monitor new CEO's strategic direction and Barbie sales stabilization. Cash flow volatility and debt levels ($2.33B) remain key watchpoints.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Mattel Inc
Mattel markets toy products that are sold to its wholesale customers and direct to retail consumers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, handheld and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Just over half of its net sales are in North America, while the remainder stem from international markets.
Read more on MAT →
